---
title: "Major stock jumps around crypto moves raise suspicions of insider activity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255089367.md"
description: "MEI Pharma’s stock jumped in mid-July. It wasn’t because of a new cancer drug. The company said it would buy $100 million of Litecoin for its cash reserves. After that, the share price went from $3 to almost $7. What was odd is that the stock had already risen in the days before the news, […] source:"
datetime: "2025-08-28T23:39:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255089367.md)
  - [en](https://longbridge.com/en/news/255089367.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255089367.md)
generator: "portal-rs"
---

# Major stock jumps around crypto moves raise suspicions of insider activity

MEI Pharma’s stock jumped in mid-July. It wasn’t because of a new cancer drug. The company said it would buy $100 million of Litecoin for its cash reserves. After that, the share price went from $3 to almost $7. What was odd is that the stock had already risen in the days before the news, \[…\] source: https://www.cryptopolitan.com/major-stock-jumps-around-crypto-moves-raise-suspicions-of-insider-activity/

### Related Stocks

- [MEIP.US](https://longbridge.com/en/quote/MEIP.US.md)

## Related News & Research

- [Is Oracle Stock a Good Buy While It's Trading Below $150?](https://longbridge.com/en/news/300960808.md)
- [‘One for the Kids,’ Says Top Investor About SpaceX Stock](https://longbridge.com/en/news/300955937.md)
- [Microsoft Could Be SpaceX's Next Big AI Customer: Bernstein Sees AI Revenue Surging Nearly 500%](https://longbridge.com/en/news/300953883.md)
- [Microsoft's blazing stock comeback isn't even close to being over, analyst says](https://longbridge.com/en/news/300955443.md)
- [Michael Burry Raises Red Flag on Oracle’s $664B Backlog and AI Spending: ‘The Customer Is Now the Lender’](https://longbridge.com/en/news/300913488.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**